Huntsworth PLC Board Changes (7707Z)
19 December 2017 - 8:27PM
UK Regulatory
TIDMHNT
RNS Number : 7707Z
Huntsworth PLC
19 December 2017
19 December 2017
Huntsworth plc
(Huntsworth or the Company)
Board Changes
The Board of Huntsworth, the international healthcare
communications and public relations group, is pleased to announce a
number of changes to the membership of its Board of Directors and
Committees, all to be effective from 1 January 2018.
Appointment of Non-Executive Director
Liz McKee Anderson will join the Board of Directors of
Huntsworth plc as an independent non-executive director.
Liz has extensive experience in the pharmaceuticals industry,
notably having held a number of senior executive roles at Johnson
& Johnson. Since April 2017, Liz has been a Board Director of
Bavarian Nordic A/S, a biotechnology company listed on the Danish
stock exchange. Liz is also an Independent Board Director of
Revolution Medicines, Inc. She holds a number of other positions in
both commercial and non-profit spheres, including the Wistar
Institute. Liz holds an MBA from Loyola University and has a degree
in Engineering. Liz will be a member of the Company's Audit
Committee.
Derek Mapp, Chairman of Huntsworth said:
"I am delighted that we have managed to recruit a very high
calibre individual to the Board with extensive experience in the
pharmaceutical and biotechnology industries. These industries are
of increasing importance to Huntsworth as can be seen with the
growth and significance of the Huntsworth Health business."
Appointment of Senior Independent Director
Andy Boland will be appointed as Huntsworth's Senior Independent
Director. Andy has been a director of Huntsworth plc since 11
August 2014, has previously served as the chair of the Audit
Committee and remains as a member of both the Audit and Nomination
Committees.
Committee Membership
The membership of Huntsworth's Committees will be:
Audit Committee:
Pat Billingham (Chair)
Liz McKee Anderson
Andy Boland
Nicky Dulieu
Nomination Committee:
Derek Mapp (Chair)
Pat Billingham
Andy Boland
Nicky Dulieu
Remuneration Committee:
Nicky Dulieu (Chair)
Pat Billingham
Enquiries to:
Citigate Dewe Rogerson +44 (0)20 7638 9571
Angharad Couch
Elizabeth Kittle
Nick Reading
Additional information:
There is no further information to be disclosed in accordance
with paragraph 9.6.13 of the Listing Rules of the UK Listing
Authority.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAZMMMZLLVGNZG
(END) Dow Jones Newswires
December 19, 2017 04:27 ET (09:27 GMT)
Huntsworth (LSE:HNT)
Historical Stock Chart
From Apr 2024 to May 2024
Huntsworth (LSE:HNT)
Historical Stock Chart
From May 2023 to May 2024